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Abstract
 
Human plasmacytoid dendritic cells (pDCs) are major producers of IFN
 
 
 
, are activated by
CpG motifs, and are believed to enter lymph nodes (LNs) via L-selectin dependent extravasa-
tion across high endothelial venules. To identify a similar murine DC type, CD11c
 
 
 
 cells in
the LNs of L-selectin–deficient and control BALB/c mice were compared, revealing a popula-
tion of CD11c
 
 
 
CD11b
 
 
 
 cells that is reduced 85% in the LNs of L-selectin–deficient mice.
These cells are Gr-1
 
 
 
B220
 
 
 
CD19
 
 
 
, either CD4
 
 
 
 or CD8
 
 
 
, and localize within T cell zones of
LNs. Freshly isolated CD11c
 
 
 
Gr-1
 
 
 
 cells express major histocompatibility complex class II at
low levels, display a plasmacytoid morphology, and survive poorly in culture. Their survival is
increased and they develop a DC-like morphology in interleukin 3 and CpG. Like human
pDCs, CD11c
 
 
 
Gr-1
 
 
 
 cells stimulate T cell proliferation after activation with CpG and pro-
duce IFN
 
 
 
 after stimulation with influenza virus. These cells also display a strain-specific varia-
tion in frequency, being fivefold increased in the LNs of BALB/c relative to C57BL/6 mice.
These CD11c
 
 
 
CD11b
 
 
 
B220
 
 
 
Gr-1
 
 
 
 cells appear to be the murine equivalent of human pDCs.
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Introduction
 
Human and murine dendritic cell (DC) subsets can be dis-
tinguished by their morphology, expression of cell surface
markers and cytokines, characteristic localization, require-
ments for growth factors, and response to activating stimuli
(1). The exact relationship between DC subsets remains un-
clear. However, increasing evidence suggests that each sub-
set has unique characteristics that contribute the develop-
ment specific immune responses (2). In mice, three major
DC subsets have been described that function in the activa-
tion of T cells: CD8
 
  
 
DCs, CD8
 
 
 
 DCs, and Langerhans-
derived cells (LCs). CD8
 
 
 
 DCs represent the classic “my-
eloid” tissue DCs originally isolated from spleen but found
in almost all tissues (3). LCs appear to be a variant of CD8
 
 
 
DCs specialized for the epidermis but functionally similar.
CD8
 
 
 
 DCs and LCs are found as immature cells in periph-
eral tissues that mature and migrate to LNs via lymphatics
upon activation (4). CD8
 
 
 
 DCs were identified as a major
splenic population that are similar to thymic DCs in their
expression of CD8
 
 
 
 and therefore proposed to be of lym-
phoid origin (5). Although studies have suggested that this
is not the case (6), their designation as “lymphoid” has con-
tinued. CD8
 
 
 
 DCs have not been identified in peripheral
tissues and the origin of these cells remains unclear, in part
because expression of their characteristic surface marker,
CD8
 
 
 
, can be induced on other DC subsets (7).
CD8
 
 
 
 DCs and LCs are found in humans and appear to
function similarly to their murine counterparts (2). Human
DCs do not express CD8 so a human equivalent of murine
CD8
 
 
 
 DCs has not been obvious. Instead, studies have
identified a circulating immature DC type known as “plas-
macytoid” DCs (pDCs). pDCs were first identified in
pathological specimens of reactive or neoplastic LNs where
they display a plasma cell–like appearance and are associ-
ated with high endothelial venules (HEVs) (8). It has since
been recognized that these cells correspond to circulating
immature CD11c
 
 
 
 DCs that can be induced to develop a
DC morphology and activate T cells when cultured in the
presence of IL-3 and CD40L (9–11). Unlike other human
DC types, pDCs produce high levels of IFN
 
 
 
 in response
to viral stimulation (12) and can be activated by immuno-
stimulatory DNA (CpG) sequences (13). Circulating pDCs
express L-selectin and stimulation appears to promote their
entry into LNs and some peripheral tissues (14, 15). Even
without stimulation, pDCs have been identified as resident
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immature cells in LNs, tonsils, and thymus (11, 16). pDCs
have been shown to stimulate both Th1 and Th2 T cell
polarization in vitro (17–19). Their function in vivo re-
mains to be demonstrated.
We now describe the identification of a novel CD11c
 
 
 
CD11b
 
 
 
Gr-1
 
 
 
B220
 
 
 
 DC type present within mouse LN
and spleen. These cells appear as immature plasmacytoid
cells when freshly isolated but develop a dendritic mor-
phology and the capacity to stimulate T cell proliferation
after activation with CpG. They produce IFN
 
 
 
 after viral
stimulation. Numbers of CD11c
 
 
 
Gr-1
 
 
 
 DCs are reduced
in the LNs of L-selectin–deficient mice, suggesting their
extravasation across HEV, and they display a marked strain-
specific variation in frequency in both LN and spleen.
These CD11c
 
 
 
Gr-1
 
 
 
 DCs appear to be the murine equiv-
alent of human pDCs.
 
Materials and Methods
 
Mice.
 
BALB/c, C57BL/6, DBA/2, 129/Sv, CD-1, and CD-
1-nu/nu mice were purchased from Charles River Laboratories.
B10.BR, C57BL/6-Rag-1
 
 
 
/
 
 
 
, and BALB/c-Rag-1
 
 
 
/
 
 
 
 mice
were purchased from The Jackson Laboratory. BALB/c-
L-selectin
 
 
 
/
 
 
 
 mice were kindly provided from Dr. T. Tedder
(Duke University, Durham, NC). All mice were kept under spe-
cific pathogen-free conditions and used at 7 to 12 wk of age ac-
cording to institutional guidelines.
 
Isolation of DCs.
 
DCs were prepared as previously reported
with some modifications (20). Briefly, peripheral LNs (cervical,
axillary, brachial, and inguinal) or spleens were minced in Mg
 
2
 
 
 
-
and Ca
 
2
 
 
 
-free HBSS/5% FCS and digested with 1mg/ml of col-
lagenase A (Roche Biochemicals) and 0.2 mg/ml of DNase I
(Sigma-Aldrich) for 35 min at 37
 
 
 
C. EDTA was added (20 mM
final concentration), the cells incubated for 5 min at room tem-
perature, passed through 70-
 
 
 
m nylon mesh, layered over RPMI
1640/10% FCS/14.5% Metrizamide (Accurate Chemical and Sci-
entific), and centrifuged at 450 
 
g
 
 for 20 min at room temperature.
Low-density cells at interface were collected and washed.
 
Flow Cytometric Analysis.
 
Cells were stained with the follow-
ing FITC, PE, allophycocyanin (APC), or biotin-conjugated
mAbs in PBS containing 0.1% NaN
 
3
 
, 10 mM EDTA, 3% FCS,
5% normal mouse serum, 5% normal rat serum, and 5 
 
 
 
g/ml Fc
block (BD PharMingen): CD3 (145–2C11), CD4 (RM4–5), CD8
(53–6.7), CD11b (M1/70), CD11c (HL3), CD40 (3/23),
CD45R/B220 (RA3–6B2), CD56 (3E2), CD62L (MEL-14),
CD80 (16–10A1), CD86 (GL1), I-A
 
b
 
, (25–9-17), I-A
 
d
 
 (AMS-32–
1), I-A/I-E (2G9), Gr-1 (RB6–8C5), isotype controls for mouse
IgG (G155–178), rat IgG
 
1
 
 (R3–34), rat IgG
 
2a
 
 (R35–95), rat IgG
 
2b
 
(A95–1) and hamster IgG (G235–2356) (BD PharMingen), and
F4/80 (Serotec). Biotinylated mAbs were followed by streptavi-
din-conjugated FITC or APC (BD PharMingen). Stained cells
were analyzed on a FACSVantage™ (Becton Dickinson) flow cy-
tometer and CELLQuest™ software. Dead cells positive for
7-aminoactinomycin D (7-AAD; BD PharMingen) staining and
auto-fluorescent cells were excluded using the FL3 channel.
 
Sorting and Culture of DCs.
 
Low-density 129/Sv spleen cells
were stained as above with anti–CD11c-PE and anti–Gr-1-APC
for 30 min on ice. After washing twice, cells were sorted and
auto-fluorescence
 
lo
 
 7-AAD
 
 
 
CD11c
 
int
 
Gr-1
 
 
 
 and CD11c
 
hi
 
Gr-1
 
 
 
cells collected. Cell purity after sorting was 
 
 
 
96%. 10
 
5
 
 sorted
DCs were cultured in 200 
 
 
 
l complete RPMI-10 (RPMI-1640
medium, 10% FCS, 20 mM Hepes, 2-ME, penicillin, and strep-
tomycin) in U-bottom 96-well plates with or without the follow-
ing supplements: recombinant mouse (rm) IL-3 (10 ng/ml),
rmIL-4 (25 ng/ml), rmGM-CSF (5 ng/ml), rmFlt-3L (20 ng/ml;
R&D Systems), phosphorothiolated CpG oligonucleotide (TC-
CATGACGTTCCTGATGCT, 1 
 
 
 
M), and GpC (TCCAT-
GAGCTTCCTGATGCT, 1 
 
 
 
M, synthesized and purified in
the Duke DNA Core Facility). For CD40 stimulation, sorted
DCs were incubated with anti-CD40 (clone HM40–3; BD
PharMingen; 5 
 
 
 
g/ml) for 30 min on ice, washed twice, and in-
cubated with goat anti–hamster IgG (10 
 
 
 
g/ml; Jackson Immu-
noResearch Laboratories). Viability of the cells was assessed by
trypan-blue exclusion in triplicate after 48 h.
 
T Cell Stimulation and DC Cytokine Production.
 
Freshly iso-
lated DCs or DCs cultured for 2 d under conditions described
above were cocultured with 10
 
5
 
 naive CD4 T cells isolated from
B10.BR mice. CD4 T cells were prepared as single cell suspen-
sions from LNs and spleens and purified by negative selection on
a MACS column (Miltenyi Biotec) using mAbs to CD8, CD11b,
CD11c, CD16/CD32 (2.4G2), B220, Gr-1, CD25 (7D4),
mouse IgM (R6–602), TER-119 (TER-119) (BD PharMingen),
and F4/80. Naive high-density cells were collected by centrifu-
gation on a 70% percoll gradient (Amersham Pharmacia Biotech).
Over 97% of the purified cells were CD4
 
 
 
CD62L
 
 
 
CD45RB
 
 
 
CD44
 
int/low
 
. 10
 
5
 
 purified T cells were cultured with graded doses
of 30 Gy gamma ray-irradiated or nonirradiated purified DCs in
200 
 
 
 
l complete RPMI-10 for 5 d. T cell proliferation cells was
measured using the WST-1 system (Roche) according to the
manufacturer’s instructions and the OD
 
450/650
 
 measured after 4 h
on a micro plate reader. To assess IFN
 
 
 
 production, 10
 
5
 
 DCs
were cultured with 1.3 HAU/ml influenza virus A/PR/8/34
(provided from Melissa Beck, UNC-Chapel Hill, Chapel Hill,
NC) in 200 
 
 
 
l complete RPMI-10 for 24 h. Supernatants were
assayed using an IFN
 
 
 
 ELISA kit (Performance Biomedical Lab-
oratories).
 
Histological Analysis.
 
Cytospins of freshly isolated or cultured
FACS
 
®
 
-purified CD11c
 
 
 
Gr-1
 
 
 
 cells were prepared (500 
 
g
 
, 5
min) and stained with Giemsa solution. Cryostat sections (6 
 
 
 
m)
of LNs or spleen were stained as previously reported with some
modification (21). After preincubation (PBS, 5% rat serum, 5%
mouse serum, 1% BSA), sections were stained with anti–B220-
FITC and anti–Gr-1-PE and analyzed on a LSM-410 confocal la-
ser microscope (ZEISS).
 
Results
 
While most DC types enter LNs by migrating from pe-
ripheral tissues, pDCs are thought to enter LNs directly
from the blood by crossing HEVs. To determine if there
are murine DC types that enter LNs via HEVs, we exam-
ined LN DC populations in L-selectin–deficient (
 
Sell
 
 
 
/
 
 
 
)
mice. Splenic DC populations were examined simulta-
neously to assist in the identification of individual DC
types. DCs were isolated from spleens and LNs of wild-
type BALB/c and BALB/c-
 
Sell
 
 
 
/
 
 
 
 mice by collagenase/
DNase digestion and partial purification on metrizimide
gradients. Low density cells were stained anti-CD11c,
CD11b, and CD8 to discriminate individual DC types.
Similar to previous reports, we find that DCs isolated from
the spleens of BALB/c mice express CD11c at high levels
(Fig. 1 A) and fall into two clear subsets: CD11b
 
hi
 
CD8
 
 
 
 DCs 
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and CD11b
 
int
 
CD8
 
 
 
 DCs (Fig. 1 B). The CD11b
 
hi
 
CD8
 
 
 
DC subset can be further subdivided into CD4
 
 
 
 and CD4
 
 
 
populations (not shown).
In BALB/c LNs, only a small proportion of low density
cells express CD11c at levels comparable to that seen in
spleen while the majority of CD11c expression occurs at
lower levels (Fig.1, C and E). Gating on CD11c
 
hi
 
 cells
demonstrates CD11b
 
hi
 
CD8
 
 
 
 and CD11b
 
int
 
CD8
 
 
 
 popula-
tions that appear similar to the splenic DC subsets (Fig. 1
D). When all LN CD11c
 
  cells are examined, three popu-
lations are apparent that are not seen in spleen (Fig. 1 F).
One of these, a CD11bintCD8  population, has been
shown to be derived from migrating LCs (22). Two other
CD11c  populations are present which are low or negative
for CD11b: a minor CD8  population and a predominant
CD8  population.
In BALB/c-Sell /  LNs, CD11c expression levels are
similar to that seen in BALB/c mice (Fig. 1 G) and the
CD11bhiCD8 , CD11bintCD8 , and CD11bintCD8  DC
populations are easily identified. However, there is a strik-
ing decrease in the number of CD11c CD11b  cells (Fig.
1 H). LN cells from heterozygous BALB/c-Sell /  litter-
mates display staining profiles similar to that of wild-type
BALB/c mice (data not shown), demonstrating that the
paucity of CD11c CD11b  cells is due to the expected re-
cessive defect at the Sell locus. This result suggests that low
density CD11c CD11b  cells enter LNs by crossing HEVs
in an L-selectin–dependent manner. The fact that these
cells express CD11c suggests that they represent a DC pop-
ulation; however, these cells do not correspond to any pre-
viously defined DC subset.
Once identified, the presence of CD11c CD11b  cells
was evaluated in other mouse strains. Interestingly, when
compared with BALB/c mice, the number of CD11c 
CD11b  cells is markedly reduced in the LNs of C57BL/6,
DBA/2, and 129/Sv mice while the number of both
CD11bhiCD8  DCs and LCs are increased in these animals
(Fig. 1 I, and data not shown). An examination of low den-
sity cells in spleen reveals that 129/Sv mice, but no other
strains, posses a large number of splenic CD11cint cells (Fig.
1 J). When segregated by CD11b and CD8 expression,
these cells display a CD11b  phenotype. CD11c CD11b 
cells from BALB/c LN and 129/Sv spleen were analyzed
for the expression of other surface markers. Strikingly,
these cells are uniformly B220  and the majority (80–90%)
express Gr-1 (Fig. 1, K and L). A small portion of CD11c 
B220 Gr-1  cells were found to be CD19  (data not
shown), thus further analysis was limited to CD11cintGr-1 
cells (gate 2 in Fig. 1 L).
Splenic CD11c Gr-1  cells are uniformly B220  but
do not express CD19, CD79b, or IgM (Fig. 2, and data
not shown), suggesting that they do not represent a B cell
lineage. CD11c Gr-1  cells can be separated into CD4 
and CD4  populations. They express CD11b and MHC
class II at very low levels and do not express CD40, CD80,
CD86, or L-selectin. CD11c Gr-1  cells from BALB/c
LNs display a similar pattern of surface marker expression
(data not shown).
Figure 1. Flow cytometric analysis of DC
populations in mouse lymph nodes and
spleens. Low density cells, prepared from the
indicated organs and mouse strains by enzy-
matic digestion and purification on Metrizi-
mide gradients, were incubated with blocking
reagents, the indicated fluorochrome-conju-
gated Abs, and 7-AAD before analysis. All
panels are gated on forward and side scatter
to exclude debris and on low autofluorescent,
7-AAD  cells. Horizontal lines in the CD11c
histograms indicate gates used for dot plots im-
mediately below. Numbered squares in L in-
dicate gates used for subsequent subset analyses
and FACS® purification. All panels are repre-
sentative of at least three separate analyses.1174 Murine Plasmacytoid Dendritic Cells
Taking advantage of the unusual combination of B220
and Gr-1 expression, the possible presence of CD11c 
Gr-1  cells in the spleens of mice other than 129/Sv was
reexamined. As shown in Fig. 3, A and B, B220 Gr-1 
cells are present in the spleens of both BALB/c and
C57BL/6 mice. However, their level of CD11c expression
is lower than occurs in LN or in 129/Sv spleen cells, mak-
ing their identification on this basis alone difficult (data not
shown). To ensure that CD11c B220 Gr-1  cells are not
derived from a mature lymphocyte population, these cells
were examined in BALB/c-Rag /  mice. B220 Gr-1 
cells are present in normal proportions (relative to other
DC types) in both the LNs and spleens of BALB/c-Rag / 
mice (Fig. 3, C and D, and data not shown). The propor-
tion of these cells was also found to be normal in the
spleens and LNs of nude mice (data not shown).
The above findings suggest that CD11c CD11b 
B220 Gr-1  cells represent a novel murine DC subset.
The fact that these cells are reduced in the LN of L-selec-
tin–deficient mice and therefore may cross HEVs suggests
they are similar to human pDCs. Human pDCs display
several characteristics that are not shared with other DC
types. These include their plasmacytoid morphology, their
dependence on IL-3, their sensitivity to activation by
CpG, and their production of IFN . These characteristics
were examined in CD11c Gr-1  cells purified by FACS®
from the spleens of 129/Sv mice (gate 2 in Fig. 1 L).
In cytospins, freshly prepared CD11c Gr-1  cells appear
as large round cells with diffuse nuclei and very rare den-
dritic-like processes (Fig. 4, A and B). This appearance is
similar to that of freshly isolated human pDCs (10, 11). Af-
ter overnight culture in IL-3 and GM-CSF, these cells ma-
ture, developing elongated processes typical of DCs (Fig. 4,
C and D). After culture in IL-3 and CpG, CD11c Gr-1 
cells develop numerous dendritic processes and display a
clear DC morphology (Fig. 4 E). CD11c Gr-1  cells were
also localized within BALB/c LNs by staining with anti-
B220 and Gr-1 and examined by confocal microscopy.
B220 Gr-1  cells appear predominately within the LN
paracortex in the region of the outer T cell zones (Fig. 4 F).
A higher power view demonstrates clear colocalization of
B220 and Gr-1 on individual cells in this region (Fig. 4 G).
When cultured in media alone (RPMI/10% FCS), the
majority ( 80%) of CD11c Gr-1  cells die within 48 h.
Survival of these cells is increased in the presence of IL-3,
GM-CSF, or flt-3L or by activation with CD40 cross-
linking or CpG (Fig. 5 A). The combination of a growth
factor and an activating agent further increases survival
only marginally.
The responsiveness of CD11c Gr-1  cells to CpG and
viral stimulation was compared with that of CD11chiGr-1 
cells (gate 3 in Fig. 1 L), which were purified simulta-
neously and comprise all other defined DC subsets in
the spleens of 129/Sv mice. When freshly isolated,
CD11cintGr-1  cells fail to stimulate significant prolifera-
tion of naive B10.BR allogenic T cells while similarly pre-
Figure 2. Surface marker expression on splenic CD11c Gr-1  cells.
Low density 129/Sv spleen cells were stained with anti-CD11c, Gr-1, and
the indicated FITC-conjugated mAbs. In each panel, staining of
CD11c Gr-1  cells (gate 2 in Fig. 1 L) is shown in bold. Unless otherwise
indicated, thin solid lines indicated staining profiles of CD11chiGr-1  cells
(gate 3 in Fig. 1 L). Staining profiles of CD11c  cells (gate 1 in Fig. 1 L)
are indicate by the number “1.” Dotted lines represent staining of isotype
controls. All panels are representative of at least three separate analyses.
Figure 3. Presence of low density B220 Gr-1  cells in BALB/c,
C57BL/6, and Rag /  mice. Low density cells were prepared from the
indicated organs of mice as described in the legend to Fig. 1, stained with
the indicated mAbs, and gated on low autofluorescent, 7-AAD  cells. (A
and B) Presence of B220 Gr-1  cells in the spleens of BALB/c and
C57BL/6 mice, respectively. (C and D) Frequency of B220 Gr-1  cells
in the LNs of BALB/c and BALB/c-Rag /  mice. The intensity of Gr-1
staining in top and bottom panels are not directly comparable due to dif-
ferences methodology.1175 Nakano et al. Brief Definitive Report
pared CD11chiGr-1  cells stimulate robust levels of T cell
proliferation (Fig. 5 B). However, after 40 h of culture in
the presence of IL-3 and CpG, CD11cintGr-1  cells gain
the capacity to stimulate T cell proliferation (Fig. 5 C).
Culture in the presence of CpG and GM-CSF also leads to
the development of T cell stimulatory capacity, though to a
lesser extent. In contrast, CD11chiGr-1  DCs stimulate T
cell proliferation when cultured in GM-CSF alone and this
is somewhat inhibited in the presence of CpG.
One of the most characteristic features of human pDC is
their expression of type I interferons after viral stimula-
tion. When cultured in the presence of influenza virus,
CD11cintGr-1  cells produce high levels of IFN  (Fig. 5
D). CD11chiGr-1  DCs demonstrate no detectable IFN 
production after viral stimulation at any concentration.
Discussion
By examining cell populations that are reduced in the
LN of L-selectin–deficient mice, we identified a novel mu-
rine cell type, CD11c CD11b B220 Gr-1  DCs, that
displays several characteristics of human pDCs. Similarities
between CD11c Gr-1  cells and human pDCs include
their apparent L-selectin–dependent migration across HEVs
(14), their plasmacytoid morphology (11), their immature
phenotype when freshly isolated from lymphoid organs
(11), their localization within T cell zones (10), their acti-
vation by CpG (13), and their production of IFN  after
viral stimulation (12). Taken together, these similarities
strongly suggest that the CD11c Gr-1  cells we describe
are the murine counterpart of human pDCs.
Several differences between the cells we describe and
human pDCs should be noted. First, the cells we describe
are CD11c , while human pDCs in blood and tissues lack
CD11c expression. The role played by CD11c on DCs is
not known, so the functional significance of this expression
difference is not clear. Second, the survival of human pDCs
is markedly increased by IL-3. While the survival of
CD11c Gr-1  cells is increased by IL-3, this effect is no
greater than that seen with GM-CSF. IL-3 does appear to
support greater levels of activation than GM-CSF or stan-
dard media alone, so some selective effect of this cytokine
is evident.
It has been suggested that splenic CD8  DCs are the
murine counterparts of human pDCs (23). Like human
pDCs, CD8  DCs have been proposed to be of lymphoid
origin, are localized within T cell zones (4), and express
IFN  after stimulation with CpG and poly I:C (23). How-
ever, murine CD8  DCs differ from human pDCs in sev-
eral important respects. Human pDC stimulate Th2 polar-
ization and the production of IL-4, IL-5, and IL-10 by
allogenic T cells (17, 18). Stimulation of Th1 polarization
by pDCs has also been demonstrated (19), suggesting that
pDC T cell polarizing activity is dependent on the methods
and stimuli used to activate these cells. In contrast, murine
lymphoid DCs have been found to be uniformly Th1 po-
larizing (24, 25). We have just begun to examine the ca-
pacity of CD11c Gr-1  cells to stimulate T cell polariza-
tion, but preliminary results suggest that, as for human
pDCs, the regulation of this activity will be complex.
Murine CD8  DCs also differ from human pDCs in
their maturational status. Freshly isolated murine CD8 
DCs express MHC class II, CD40, and CD80, and can
stimulate T cell proliferation (20). Human pDCs, like
CD11c Gr-1  cells, express MHC class II at very low lev-
els, do not express CD40 or CD80, and fail to stimulate T
Figure 4. Morphology and localization of CD11c Gr-1  cells. (A–E)
Cytospins of FACS®-purified CD11c Gr-1  cells were Giemsa-stained
and photographed at 100 . (A and B) Appearance of freshly isolated
CD11c Gr-1  cells. (C and D) CD11c Gr-1  cells after overnight cul-
ture in IL-3 and GM-CSF. (E) CD11c Gr-1  cells after activation in IL-3
and CpG for 40 h. (F) Confocal microscopy of BALB/c LN frozen section
stained with anti–B220-FITC (green) and anti–Gr-1-PE (red). Colocaliza-
tion of B220 and Gr-1 signals appears as yellow. (G) Higher magnification
demonstrates individual B220 Gr-1  cells within T cell zone.1176 Murine Plasmacytoid Dendritic Cells
cell proliferation (10). Finally, as shown in Fig. 1, the fre-
quency of CD11b CD8  DCs in peripheral LNs is only
slightly decreased by the absence of L-selectin expression.
Based on their expression of L-selectin and association
with HEVs in pathologic sections, human pDCs are be-
lieved to enter LNs by extravasation across HEVs (14).
The marked paucity of CD11c Gr-1  cells in the LNs of
L-selectin–deficient mice suggests that these cells also en-
ter LNs by L-selectin–mediated extravasation across HEV.
We were not able to test this hypothesis directly because
CD11c Gr-1  cells, like human pDCs (11), are L-selec-
tin  when freshly isolated from secondary lymphoid or-
gans. Such studies will likely require the identification and
purification of circulating CD11c Gr-1  cell precursors
from blood or bone marrow. The above findings suggest
that CD11c Gr-1  cells, rather than CD8  DCs, are the
true murine pDC equivalent.
Given the high frequency of CD11c Gr-1  cells in
some mouse strains, it is somewhat surprising that this pop-
ulation has not been described previously. Several reasons
may account for this. First, murine DC populations have
been studied predominately in spleen and predominately in
C57BL/6 or closely related strains of mice. As we show,
CD11c Gr-1  cells represent only a minor population in
the spleens of C57BL/6 mice and express very low levels of
CD11c. Second, most murine DC purification protocols
have included the depletion of B220  or Gr-1  cells.
Third, it is likely that some investigators have identified
CD11c Gr-1  cells, but believed them to represent a con-
taminating cell type. In one case, CD11c B220  cells were
purified from Peyer’s patches, but found to express CD19
mRNA and therefore not further examined (26). We have
found that a proportion of Peyer’s patch CD11c B220 
cells also express Gr-1 (data not shown), suggesting that
they are similar to the cells we find in LNs and spleen.
To our knowledge, the finding of Gr-1 expression by a
DC population is novel. However, B220  DC types have
been reported on several occasions. A CD11c B220 
DEC-205  DC population has been shown to arise from
cultures of purified CD19  pro-B cells in the presence of
multiple cytokines (27). Unlike the cells we describe, these
do not express CD4, CD8, or Gr-1 but they do appear to
lose CD19 expression upon maturation. More recently, a
DEC205 B220 CD19  DC population has been de-
scribed that can be propagated from mouse liver cells cul-
tured in IL-3 and anti-CD40 (28). These cells appear to
stimulate the apoptosis of activated T cells and prolong car-
diac allograft survival. They differ from the population we
describe in that they are predominately CD11c , CD4 ,
and CD8  and display a mature DC phenotype. A
CD8  CD11c B220 CD19  cell population has been
identified in murine bone marrow that facilitates the en-
graftment of allogenic stem cells (29). These cells display a
plasmacytoid morphology and appear similar to the CD8 
subset of our CD11c Gr-1  cells. These findings suggest
that CD11c Gr-1  DCs may be part of a broader DC sub-
set whose specific phenotypes and activities are dependent
on their state of maturation and activation.
Several roles for pDCs have been proposed. These cells
may respond to viral infection by migrating across HEV
Figure 5. Survival and activities of
CD11c Gr-1  cells. CD11c Gr-1  (Gr-1 
DC) and CD11chiGr-1  (Gr-1- DC) cells
were purified by FACS® from the spleens of
129/Sv mice. (A) Survival of CD11c Gr-1 
cells after 48 h of culture in the indicated
agents. (B) Proliferation of naive allogenic T
cells incubated with the indicated numbers
of freshly isolated CD11c Gr-1  or
CD11chiGr-1  cells. (C) Proliferation of na-
ive allogenic T cells incubated with cyto-
kine and CpG activated CD11c Gr-1  or
CD11chiGr-1  cells. A–C are representative
of three independent experiments, each pre-
formed in triplicate (mean   SD; *P   
0.05; **P   0.01; ***P   0.005; ****P  
0.001). (D) IFN  production by
CD11c Gr-1  or CD11chiGr-1  cells incu-
bated 24 h in the presence of absence of 1.3
HAU/ml influenza virus (mean   SD, n  
2). Dashed line, detection limit of the assay.1177 Nakano et al. Brief Definitive Report
and presenting viral Ag in the context of IFN , perhaps via
the stimulation of CCR7 (14, 16). pDCs have also been
shown to enter peripheral tissues (15) and may subse-
quently migrate to LNs via lymphatics. pDCs may also act
to regulate T cell polarization. Stimulation by CpG motifs
or viral products may lead to IFN  production and Th1
polarization while, under most other conditions, pDCs are
Th2 polarizing. Consistent with this, CD11c Gr-1  DCs
are increased in the LNs of BALB/c mice, a strain with an
increased propensity to develop Th2 polarized immune re-
sponses. Finally, the similarity of CD11c Gr-1  cells to
DC types in liver and bone marrow that facilitate transplant
survival suggests that these cells may have some immune
inhibitory function. This may explain their substantial pres-
ence within secondary lymphoid organs as an immature
DC population. Immature DCs have been shown to re-
duce Ag-specific immune responses, probably by stimulat-
ing the production of regulatory T cells (30). At present,
the contribution of pDCs to any or all of these immune
functions remains purely speculative. Hopefully, the identi-
fication of these cells in mice will lead to a better under-
standing of their function during immune response.
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